Mallinckrodt New Name

Tyco Healthcare has announced that Covidien will be the new name of the heathcare division that will become an independent publicly traded company this spring.  The Covidien brand will be the master identifier that unites Tyco Healthcare’s brand names, including Mallinckrodt.          For more information...

 

Triad Isotopes

Triad Isotopes Inc. was recently formed with the acquisition and merger of three nuclear pharmacy companies: Diversified Pharmacy Group, Cox Nuclear Pharmacies and Coastal Nuclear Pharmacies. Funding was provided by Parthenon Capital.  There are currently 20 pharmacies located in the southeastern U.S with plans for expansion and acquisitions.  For more information...

 

BMS Restructuring Sales Force

Bristol-Myers Squibb, manufacturer of Cardiolite, recently laid off approximately one half of their sales force and restructured the existing sales territories.  The patent on Cardiolite is due to expire at the end of the year unless an extension for a pediatric indication extends the expiration to the end of June 2008.

 

BPS Specialty Council on Nuclear Pharmacy

Congratulations to Fred Gattas for being selected to serve on the Board of Pharmaceutical Specialties Council on Nuclear Pharmacy.  Congratulations to George Hinkle for his reappointment and selection as Chair of the council.  Other nuclear pharmacists serving on the council include Wendy Galbraith (Vice-Chair), Richard Hammes, Walter Miller, and John Sterzinger. 

 

Congratulations to 25 New BCNPs

There currently 501 Board Certified Nuclear Pharmacists (BCNP) in the U.S., including 25 that recently joined the ranks.  Congratulations to the newest BCNPs as listed on the recent BPS news release.

 

Stolen Mo-99/Tc-99m Generator

Earlier this month a Mo-99/Tc-99m generator was stolen from an unlocked courier's vehicle in Milwaukee.  The local sheriff and FBI are investigating.  "This event illustrates a serious consequence resulting from a brief lapse in security, and should serve to reinforce the importance that radiopharmacy delivery staff must follow all security procedures."  Posted by Jim Ponto on the APhA Nuclear eCommunity.

Bayer Schering to develop PET brain imaging agents
Bayer Schering Pharma has signed a license and option agreement with two Japanese companies to develop imaging compounds for detecting neurodegenerative diseases such as Alzheimer's and Parkinson's diseases.